Applicant, as named in the Orange Book

Syndax

Next listed expiry: Revuforj on 18 Dec 2042. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	Earliest generic entry	Basis
Revuforj NDA 218944 · 3 strengths revumenib citrate	revumenib citrate	18 Dec 2042 patent	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.